Literature DB >> 12636173

Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids.

David Lechuga-Ballesteros1, Aziz Bakri, Danforth P Miller.   

Abstract

PURPOSE: Use a microcalorimetric technique to measure the interactions between water vapor and amorphous pharmaceutical solids and describe the relationship between long-term physical stability and the storage relative humidity (RH) at constant temperature.
METHODS: A thermal activity monitor was used to characterize interactions of water vapor with spray-dried amorphous sucrose, lactose, raffinose, and sodium indomethacin. Differential scanning calorimetry was used to measure glass transition temperature, Tg. X-ray powder diffraction was used to confirm that the spray-dried samples were amorphous. Scanning electron microscopy was used to examine particle morphology. Specific surface area was determined by BET analysis of nitrogen and krypton adsorption isotherms.
RESULTS: The moisture-induced thermal activity traces (MITATs) of the materials in this study exhibit general behavior that helps explain the effect of moisture content on the physical stability of the glassy phase at a given storage temperature. At some RH threshold, RHm, the MITAT exhibits a dramatic increase in the energy of interaction between water vapor and the glass that cannot be explained by a phase or morphology change. Calorimetric data indicate that water vapor-solid interactions are reversible below RHm; above RHm, energetic hysteresis is observed and water-water interactions predominate. In addition, the MITAT was deconvoluted into sorptive and nonsorptive components, making it possible to assign the observed heat flow to unique thermal events. Samples stored at a RH just below RHm for more than 2 months show no evidence of morphology or phase change. In addition, the MITAT can be deconvoluted into sorptive and nonsorptive components by using a twin-calorimeter arrangement. This analysis provides specificity to the microcalorimetric analysis and helps explain the nature of the physical changes that occur during the hydration glassy phase.
CONCLUSIONS: The MITAT is a useful tool to determine the onset of moisture-induced physical instability of glassy pharmaceuticals and may find a broad application to determine appropriate storage conditions to ensure long-term physical stability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12636173     DOI: 10.1023/a:1022406709912

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Simultaneous determination of the heat and the quantity of vapor sorption using a novel microcalorimetric method.

Authors:  V P Lehto; E Laine
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

Review 2.  Protein-water interactions determined by dielectric methods.

Authors:  R Pethig
Journal:  Annu Rev Phys Chem       Date:  1992       Impact factor: 12.703

3.  Amorphous-to-crystalline transformation of sucrose.

Authors:  J T Carstensen; K Van Scoik
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

4.  Dielectric and gravimetric studies of water binding to lysozyme.

Authors:  S Bone
Journal:  Phys Med Biol       Date:  1996-08       Impact factor: 3.609

5.  The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity.

Authors:  V Andronis; G Zografi
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

6.  Glass fragility and the stability of pharmaceutical preparations--excipient selection.

Authors:  R H Hatley
Journal:  Pharm Dev Technol       Date:  1997-08       Impact factor: 3.133

7.  [A new relationship between tablet formation and moisture of the raw material].

Authors:  R Hüttenrauch; J Jacob
Journal:  Pharmazie       Date:  1977-04       Impact factor: 1.267

8.  Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.

Authors:  P Tong; G Zografi
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

9.  Hydration and dehydration of crystalline and amorphous forms of raffinose.

Authors:  A Saleki-Gerhardt; J G Stowell; S R Byrn; G Zografi
Journal:  J Pharm Sci       Date:  1995-03       Impact factor: 3.534

10.  The use of solution theories for predicting water vapor absorption by amorphous pharmaceutical solids: a test of the Flory-Huggins and Vrentas models.

Authors:  B C Hancock; G Zografi
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

View more
  6 in total

1.  Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.

Authors:  Danforth P Miller; David Lechuga-Ballesteros
Journal:  Pharm Res       Date:  2006-09-06       Impact factor: 4.200

2.  Detection of low levels of amorphous lactose using H/D exchange and FT-Raman spectroscopy.

Authors:  Paul T Whiteside; Shen Y Luk; Claire E Madden-Smith; Paul Turner; Nikin Patel; Michael W George
Journal:  Pharm Res       Date:  2008-09-03       Impact factor: 4.200

3.  Overcoming poor tabletability of pharmaceutical crystals by surface modification.

Authors:  Limin Shi; Changquan Calvin Sun
Journal:  Pharm Res       Date:  2011-06-28       Impact factor: 4.200

4.  Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations.

Authors:  Dexter J D'Sa; David Lechuga-Ballesteros; Hak-Kim Chan
Journal:  Pharm Res       Date:  2014-04-24       Impact factor: 4.200

5.  The influence of surfactant on PLGA microsphere glass transition and water sorption: remodeling the surface morphology to attenuate the burst release.

Authors:  C Bouissou; J J Rouse; R Price; C F van der Walle
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

6.  Isothermal microcalorimetry of pressurized systems II: effect of excipient and water ingress on formulation stability of amorphous glycopyrrolate.

Authors:  Dexter J D'Sa; David Lechuga-Ballesteros; Hak-Kim Chan
Journal:  Pharm Res       Date:  2014-09-06       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.